Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells

被引:82
作者
Inoue, A
Omoto, Y
Yamaguchi, Y
Kiyama, R
Hayashi, SI [1 ]
机构
[1] Saitama Canc Ctr, Res Inst, Div Endocrinol, 818 Komuro, Ina, Saitama 3620806, Japan
[2] AIST, Tsukuba Ctr, Res Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan
[3] InfoGenes Co Ltd, Tsukuba, Ibaraki 3058566, Japan
关键词
D O I
10.1677/jme.0.0320649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen has been c osely associated with the genesis and malignant progression of breast cancer. However, the molecular mechanism underlying the effects of estrogen is far from being completely clarified. We previously developed a custom-made cDNA microarray consisting of approximately 200 estrogen-responsive genes in breast cancer cells. Using this system, we found one estrogen-induced gene in various cancer cell lines, including breast cancer MCF-7 cells, which encode a zinc-finger transcription factor, EGR3 (early growth response 3). Northern blot analysis of estradiol-treated MCF-7 cells showed rapid and robust induction of Egr3, and addition of cycloheximide or ICI 182,780 suggested that Egr3 is the bona fide target for the estrogen receptor alpha (ERalpha.). Using stable transformants derived from MCF-7 cells which were transfected with expression-controllable Egr3-expression vector, we demonstrated that Nab2 is one of the target genes for EGR3. Microarray analysis of the transformants revealed other candidate EGR3-induced genes. These strategies could be useful for analyzing downstream genes of ERalpha, and may contribute to elucidating the extensive signaling network of estrogen stimuli. Furthermore, a reporter assay using the upstream region of fasL probably involving escape from the immune system revealed that fasL is another target gene for EGR3. The roles of EGR3 in the physiology of breast cancer are discussed.
引用
收藏
页码:649 / 661
页数:13
相关论文
共 38 条
[1]   Estrogen responsiveness and control of normal human breast proliferation [J].
Anderson, E ;
Clarke, RB ;
Howell, A .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (01) :23-35
[2]  
Bouras T, 2002, CANCER RES, V62, P1289
[3]   ACTIVATION OF PS2 GENE-TRANSCRIPTION IS A PRIMARY RESPONSE TO ESTROGEN IN THE HUMAN-BREAST CANCER CELL-LINE MCF-7 [J].
BROWN, AMC ;
JELTSCH, JM ;
ROBERTS, M ;
CHAMBON, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6344-6348
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   Transcriptional activation of c-fos protooncogene by 17β-estradiol:: Mechanism of aryl hydrocarbon receptor-mediated inhibition [J].
Duan, RQ ;
Porter, W ;
Samudio, I ;
Vyhlidal, C ;
Kladde, M ;
Safe, S .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) :1511-1521
[6]   Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer [J].
Fanelli, MA ;
VargasRoig, LM ;
Gago, FE ;
Tello, O ;
DeAngelis, RL ;
Ciocca, DR .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (03) :217-228
[7]   RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer [J].
Finlin, BS ;
Gau, CL ;
Murphy, GA ;
Shao, HP ;
Kimel, T ;
Seitz, RS ;
Chiu, YF ;
Botstein, D ;
Brown, PO ;
Tamanoi, F ;
Andres, DA ;
Perou, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42259-42267
[8]   EARLY GROWTH-RESPONSE PROTEIN 1(EGR-1) - PROTOTYPE OF A ZINC-FINGER FAMILY OF TRANSCRIPTION FACTORS [J].
GASHLER, A ;
SUKHATME, VP .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 50, 1995, 50 :191-224
[9]   The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas [J].
Gutierrez, LS ;
Eliza, M ;
Niven-Fairchild, T ;
Naftolin, F ;
Mor, G .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (03) :245-253
[10]   Two promoters in expression of estrogen receptor messenger RNA in human breast cancer [J].
Hayashi, S ;
Imai, K ;
Suga, K ;
Kurihara, T ;
Higashi, Y ;
Nakachi, K .
CARCINOGENESIS, 1997, 18 (03) :459-464